艾布基纳斯可以作为瘤进展和转移的抑制剂
Melissa A Marchal1, Devon L Moose2, Afshin Varzavand1
1Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, IA, United States.
阿布尔家族的激酶抑制瘤的进展和转移. 酶缺陷促进了侵略性的癌症表型,突出了它们在某些癌症中的瘤抑制作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 在白血病中,AB1家族基因酶被认为是原瘤基因,在固体瘤中具有前瘤作用.
- 新出现的证据表明,Abl酶可以抑制瘤细胞的增殖,运动性和在特定情况下的生长.
研究的目的:
- 调查ABL激酶在前列腺癌进展和转移中的作用.
- 阐明ABL激酶枯竭对瘤细胞行为和信号通路的影响.
主要方法:
- 利用RNA干扰 (RNAi) 来产生Abl缺乏的前列腺癌细胞.
- 采用了体内静态模型来研究瘤进展和转移.
- 在实验室中评估瘤细胞运动性,3D生长和信号通路.
主要成果:
- 酶缺乏导致了攻击性增加,转移,AKT通路激活,增强3D原基质生长和细胞运动.
- 抑制AKT通路逆转了Abl缺乏细胞中3D增长的增加.
- 伊马替尼治疗和阿布尔基纳斯抑制促进了各种瘤细胞的3D生长和纤维细胞殖民地形成.
结论:
- 在实验室中,AB1家族激酶表现出对恶性表型的瘤抑制功能.
- 在活体中抑制瘤进展和转移方面,ABK酶起着至关重要的作用.
更多相关视频
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
